Alector (ALEC) Cash & Equivalents Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) Cash & Equivalents Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -25.80% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -17.71% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -15.41% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 8.23% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 47.78% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -23.18% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 37.45% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -21.12% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -3.85% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -23.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.06% |
| Mar 31, 2026 | -26.72% |
| Dec 31, 2025 | -24.73% |
| Sep 30, 2025 | -25.39% |
| Jun 30, 2025 | -36.18% |
| Mar 31, 2025 | -56.29% |
| Dec 31, 2024 | -53.53% |
| Sep 30, 2024 | -58.41% |
| Jun 30, 2024 | -27.68% |
| Mar 31, 2024 | -13.14% |
| Dec 31, 2023 | 14.27% |
| Sep 30, 2023 | 6.26% |
| Jun 30, 2023 | 12.45% |
| Mar 31, 2023 | 6.71% |
| Dec 31, 2022 | 19.85% |
| Sep 30, 2022 | 28.43% |
| Jun 30, 2022 | 35.52% |
| Mar 31, 2022 | 95.38% |
| Dec 31, 2021 | 71.31% |
| Sep 30, 2021 | 130.94% |